← Insider buys
TCON

Tracon Pharmaceuticals, Inc.

Puissance Cross-Border Opportunities V LLC sold $1.1M of Tracon Pharmaceuticals, Inc.

10% owner

Sold$1,127,379
$2.93Price
384,130Shares
−83%Stake

What TCON did after the filing

Prices for TCON after this filing aren't in yet.

Traded Thu, Dec 5. Filed Wed, Dec 11, 5:47 AM ET, before the open. Not investment advice.